Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 134

1.

Overview: special focus vaccine acceptance.

Feemster KA.

Hum Vaccin Immunother. 2013 Aug;9(8):1752-4. doi: 10.4161/hv.26217. Epub 2013 Aug 1.

2.

Vaccine hesitancy: an overview.

Dubé E, Laberge C, Guay M, Bramadat P, Roy R, Bettinger J.

Hum Vaccin Immunother. 2013 Aug;9(8):1763-73. doi: 10.4161/hv.24657. Epub 2013 Apr 12. Review.

3.

Strengthening vaccination policies in Latin America: an evidence-based approach.

Tapia-Conyer R, Betancourt-Cravioto M, Saucedo-Martínez R, Motta-Murguía L, Gallardo-Rincón H.

Vaccine. 2013 Aug 20;31(37):3826-33. doi: 10.1016/j.vaccine.2012.12.062. Epub 2013 Jan 25. Review.

PMID:
23357196
4.
5.
6.

Public trust and vaccine acceptance--international perspectives.

Ozawa S, Stack ML.

Hum Vaccin Immunother. 2013 Aug;9(8):1774-8. doi: 10.4161/hv.24961. Epub 2013 Jun 3. Review.

7.

Financial requirements of immunisation programmes in developing countries: a 2004-2014 perspective.

Peny JM, Gleizes O, Covilard JP.

Vaccine. 2005 Aug 31;23(37):4610-8.

PMID:
15979769
8.

Global routine vaccination coverage, 2009.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2010 Oct 29;59(42):1367-71.

9.

Sustainable introduction of affordable new vaccines: the targeting strategy.

Batson A.

Vaccine. 1998 Nov;16 Suppl:S93-8. Review.

PMID:
9915047
10.

Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia 2003 to 2006.

Menzies R, Turnour C, Chiu C, McIntyre P.

Commun Dis Intell Q Rep. 2008 Jun;32 Suppl:S2-67. Review.

11.

Estimated economic benefits during the 'decade of vaccines' include treatment savings, gains in labor productivity.

Stack ML, Ozawa S, Bishai DM, Mirelman A, Tam Y, Niessen L, Walker DG, Levine OS.

Health Aff (Millwood). 2011 Jun;30(6):1021-8. doi: 10.1377/hlthaff.2011.0382.

12.

Introducing new vaccines in developing countries.

Kochhar S, Rath B, Seeber LD, Rundblad G, Khamesipour A, Ali M; Vienna Vaccine Safety Initiative.

Expert Rev Vaccines. 2013 Dec;12(12):1465-78. doi: 10.1586/14760584.2013.855612. Review.

PMID:
24195483
13.

World Health Organization perspectives on the contribution of the Global Alliance for Vaccines and Immunization on reducing child mortality.

Bustreo F, Okwo-Bele JM, Kamara L.

Arch Dis Child. 2015 Feb;100 Suppl 1:S34-7. doi: 10.1136/archdischild-2013-305693.

PMID:
25613965
14.

How society should respond to the risk of vaccine rejection.

Ropeik D.

Hum Vaccin Immunother. 2013 Aug;9(8):1815-8. doi: 10.4161/hv.25250. Epub 2013 Jun 6. Review.

15.
16.

Childhood vaccination: achievements and challenges.

Ndumbe P.

Afr Health. 1996 Sep;18(6):18-9.

PMID:
12291732
17.

Global routine vaccination coverage, 2010.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2011 Nov 11;60(44):1520-2.

18.

Capacity for a global vaccine safety system: the perspective of national regulatory authorities.

Graham JE, Borda-Rodriguez A, Huzair F, Zinck E.

Vaccine. 2012 Jul 13;30(33):4953-9. doi: 10.1016/j.vaccine.2012.05.045. Epub 2012 May 30.

PMID:
22658930
19.
20.

Vaccine hesitancy, vaccine refusal and the anti-vaccine movement: influence, impact and implications.

Dubé E, Vivion M, MacDonald NE.

Expert Rev Vaccines. 2015 Jan;14(1):99-117. doi: 10.1586/14760584.2015.964212. Epub 2014 Nov 6. Review.

PMID:
25373435
Items per page

Supplemental Content

Write to the Help Desk